According to World Health Organization, neurologic disorders affect up to one billion people worldwide, irrespective of age, education or income.

Moreover, increased life expectancy and the ageing of the general population in both developed and developing countries are likely to increase the prevalence of many chronic and progressive physical and mental conditions, including neurological disorders.

Significant investment is being made to conduct studies in this field that include: Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), carpal tunnel syndrome, Huntington’s disease, dementia, memory loss, migraine headaches, multiple sclerosis, muscular dystrophy, Parkinson’s disease, strokes, Tourette’s syndrome, and others. But studies in this field can be difficult to navigate.

Eurotrials is committed to both prevention and treatment of neurologic disorders through biopharmaceutical, medical device and diagnostic development.

With more than 20 years of experience in the industry, our multidisciplinary team includes medical, operational, strategy and regulatory specialists, as well as market access experts who plan and implement worldwide studies, guiding you and providing you support in every step of the product lifecycle. This experience will help you develop the best strategies to conduct studies and better navigate the regulatory process for the benefit of your study.

Long-term relationships with medical and scientific leaders and research centers in Europe and Latin America contribute to valued expert input for your projects from project design to patient engagement.